Abstract
Summary
Anthropometric adjustments of bone measurements are necessary in Prader-Willi syndrome patients to correctly assess the bone status of these patients. This enables physicians to get a more accurate diagnosis of normal versus abnormal bone, allow for early and effective intervention, and achieve better therapeutic results.
Introduction
Bone mineral density (BMD) is decreased in patients with Prader-Willi syndrome (PWS). Because of largely abnormal body height and weight, traditional BMD Z-scores may not provide accurate information in this patient group. The goal of the study was to assess a cohort of individuals with PWS and characterize the development of low bone density based on two adjustment models applied to a dataset of BMD and bone mineral content (BMC) from dual-energy X-ray absorptiometry (DXA) measurements.
Methods
Fifty-four individuals, aged 5–20 years with genetically confirmed PWS, underwent DXA scans of spine and hip. Thirty-one of them also underwent total body scans. Standard Z-scores were calculated for BMD and BMC of spine and total hip based on race, sex, and age for all patients, as well as of whole body and whole-body less head for those patients with total-body scans. Additional Z-scores were generated based on anthropometric adjustments using weight, height, and percentage body fat and a second model using only weight and height in addition to race, sex, and age.
Results
As many PWS patients have abnormal anthropometrics, addition of explanatory variables weight, height, and fat resulted in different bone classifications for many patients. Thus, 25–70 % of overweight patients, previously diagnosed as normal, were subsequently diagnosed as below normal, and 40–60 % of patients with below-normal body height changed from below normal to normal depending on bone parameter.
Conclusions
This is the first study to include anthropometric adjustments into the interpretation of BMD and BMC in children and adolescents with PWS. This enables physicians to get a more accurate diagnosis of normal versus abnormal BMD and BMC and allows for early and effective intervention.
Similar content being viewed by others
References
Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14:10–26
2 Prader-Willi Syndrome Association (USA) (2008) Osteoporosis evaluation and therapy in Prader-Willi syndrome. Consensus statement of the PWSA (USA) Clinical Advisory Board. The gathered view (ISSN 1077-9965) 94:3763–3771.
Hirsch HJ, Geva-Eldar T, Benarroch F, Rubinstein O, Gross-Tsur V (2009) Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab 94:2262–2268
Eldar-Geva T, Hirsch HJ, Benarroch F, Rubinstein O, Gross-Tsur V (2010) Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction. Eur J Endocrinol 162:377–384
Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC (2012) Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. J Clin Endocrinol Metab 97:E452–E459
Radicioni AF, Di Giorgio G, Grugni G, Cuttini M, Losacco V, Anzuini A, Spera S, Marzano C, Lenzi A, Cappa M, Crinò A (2012) Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. Clin Endocrinol (Oxf) 76:72–77
Hirsch HJ, Geva-Eldar T, Benarroch F, Pollak Y, Gross-Tsur V (2015) Sexual dichotomy in gonadal function in Prader-Willi syndrome (PWS): a longitudinal study from early infancy through the fourth decade. Hum Reprod 30:2587–2596
Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID (2001) Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet 103:216–222
Vestergaard P, Kristensen K, Bruun JM, Østergaard JR, Heickendorff L, Mosekilde L, Richelsen B (2004) Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index—a cross-sectional study. J Pediatr 144:614–619
Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruyère O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, Vestergaard P (2012) Antidepressant medications and osteoporosis. Bone 51:606–613
Khare M, Gold JA, Wencel M, Billimek J, Surampalli A, Duarte B, Pontello A, Galassetti P, Cassidy S, Kimonis VE (2014) Effect of genetic subtypes and growth hormone treatment on bone mineral density in Prader-Willi syndrome. J Pediatr Endocrinol Metabol 27:511–518
Bakker NE, Kuppens RJ, Siemensma EP, van Wijngaarden RF T-de L, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Van Alfen AA, Van Leeuwen M, Van Wieringen H, Wegdam-den Boer ME, Zwaveling-Soonawala N, Hokken-Koelega AC (2015) Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment. J Clin Endocrinol Metab 100:1609–1618
Schoenau E, Frost HM (2002) The “muscle-bone unit” in children and adolescents. Calcif Tissue Int 70:405–407
Short DF, Gilsanz V, Kalkwarf HJ, Lappe JM, Oberfield S, Shepherd JA, Winer KK, Zemel BS, Hangartner TN (2015) Anthropometric models of bone mineral content and areal bone mineral density based on the Bone Mineral Density in Childhood Study. Osteoporos Int 26:1099–1108
15 World Health Organization (2015) Growth reference data for 5–19 years. http://www.who.int/growthref/en/; accessed 25 September 2015.
De Lind van Wijngaarden RFA, Festen DAM, Otten BJ, van Mil EGAH, Rotteveel J, Odink RJ, van Leeuwen M, Haring DAJP, Bocca G, Houdijk AM, Hokken-Koelega ACS (2009) Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized clinical trial. J Clin Endocrinol Metab 94:3763–3771
Rubin DA, Cano-Sokoloff N, Castner DL, Judelson DA, Wright P, Duran A, Haqq AM (2013) Update on body composition and bone density in children with Prader-Willi syndrome. Horm Res Paediatr 79:271–276
Nakamura Y, Murakami N, Ilda T, Asano S, Ozeki S, Nagal T (2014) Growth hormone treatment for osteoporosis in patients with scoliosis of Prader-Willi syndrome. J Orthop Sci 19:877–882
Gordon CM, Leonard MB, Zemel BS (2014) 2013 Pediatric position development conference: executive summary and reflections. J Clin Densitom 17:219–224
International Society for Clinical Densitometry 2013 ISCD Official Positions—Pediatric. http://www.iscd.org/official-positions/2013-iscd-official-positions-pediatric/
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 296 kb)
Rights and permissions
About this article
Cite this article
Hangartner, T.N., Short, D.F., Eldar-Geva, T. et al. Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome. Osteoporos Int 27, 3457–3464 (2016). https://doi.org/10.1007/s00198-016-3671-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-016-3671-y